Suppr超能文献

姜纳米粒介导 Foxa2 诱导可预防高脂饮食诱导的胰岛素抵抗。

Ginger nanoparticles mediated induction of Foxa2 prevents high-fat diet-induced insulin resistance.

机构信息

James Graham Brown Cancer Center, Department of Microbiology & Immunology, University of Louisville, KY 40202, USA.

Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY40202, USA.

出版信息

Theranostics. 2022 Jan 1;12(3):1388-1403. doi: 10.7150/thno.62514. eCollection 2022.

Abstract

The obesity epidemic has expanded globally, due in large part to the increased consumption of high-fat diets (HFD), and has increased the risk of major chronic diseases, including type 2 diabetes. Diet manipulation is the foundation of prevention and treatment of obesity and diabetes. The molecular mechanisms that mediate the diet-based prevention of insulin resistance, however, remain to be identified. Here, we report that treatment with orally administered ginger-derived nanoparticles (GDNP) prevents insulin resistance by restoring homeostasis in gut epithelial Foxa2 mediated signaling in mice fed a high-fat diet (HFD). Ginger-derived nanoparticles (GDNP) were added into drinking water to treat high-fat diet fed mice for at least one year or throughout their life span. A micro array profile of intestinal, liver and fat tissue of GDNP treated mice was used to analyze their gene expression profile. Genes associated with metabolism or insulin signaling were further quantified using the real time polymerase chain reaction (RT-PCR). Surface plasmon resonance (SPR) was used for determining the interaction between Foxa2 protein and phosphatic acid lipid nanoparticles. HFD-feeding inhibited the expression of Foxa2; the GDNPs increased the expression of Foxa2 and protected Foxa2 against Akt-1 mediated phosphorylation and subsequent inactivation of Foxa2. Increasing expression of Foxa2 leads to altering the composition of intestinal epithelial cell (IEC) exosomes of mice fed a HFD and prevents IEC exosome mediated insulin resistance. Collectively, oral administration of GDNP prevents insulin resistance in HFD mice. Interestingly, oral administration of GDNP also extended the life span of the mice and inhibited skin inflammation. Our findings showed that GDNP treatment can prevent HFD-induced obesity and insulin resistance via protecting the Foxa2 from Akt-1 mediated phosphorylation. GDNP treatment provides an alternative approach based on diet manipulation for the development of therapeutic interventions for obesity.

摘要

肥胖症在全球范围内蔓延,很大程度上是由于高脂肪饮食(HFD)的消费增加,增加了 2 型糖尿病等主要慢性疾病的风险。饮食控制是预防和治疗肥胖和糖尿病的基础。然而,介导基于饮食的胰岛素抵抗预防的分子机制仍有待确定。在这里,我们报告说,口服给予姜衍生的纳米颗粒(GDNP)通过恢复高脂肪饮食喂养的小鼠肠道上皮 Foxa2 介导的信号转导的体内平衡来预防胰岛素抵抗。将姜衍生的纳米颗粒(GDNP)添加到饮用水中,以治疗至少一年或整个生命周期内喂食高脂肪饮食的小鼠。使用 GDNP 处理的小鼠的肠道、肝脏和脂肪组织的微阵列图谱分析其基因表达谱。使用实时聚合酶链反应(RT-PCR)进一步定量与代谢或胰岛素信号相关的基因。表面等离子体共振(SPR)用于确定 Foxa2 蛋白与磷酸脂纳米颗粒之间的相互作用。HFD 喂养抑制了 Foxa2 的表达;GDNPs 增加了 Foxa2 的表达,并防止 Akt-1 介导的 Foxa2 磷酸化和随后的 Foxa2 失活。Foxa2 表达的增加导致改变高脂肪饮食喂养的小鼠肠道上皮细胞(IEC)外泌体的组成,并防止 IEC 外泌体介导的胰岛素抵抗。总的来说,口服 GDNP 可预防 HFD 小鼠的胰岛素抵抗。有趣的是,口服 GDNP 还延长了小鼠的寿命并抑制了皮肤炎症。我们的研究结果表明,GDNP 治疗可以通过保护 Foxa2 免受 Akt-1 介导的磷酸化来预防 HFD 诱导的肥胖和胰岛素抵抗。GDNP 治疗为基于饮食控制的肥胖治疗干预措施的开发提供了一种替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b306/8771553/eff950f53d0a/thnov12p1388g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验